Literature DB >> 24055719

Biophysics of cell membrane lipids in cancer drug resistance: Implications for drug transport and drug delivery with nanoparticles.

Chiranjeevi Peetla1, Sivakumar Vijayaraghavalu, Vinod Labhasetwar.   

Abstract

In this review, we focus on the biophysics of cell membrane lipids, particularly when cancers develop acquired drug resistance, and how biophysical changes in resistant cell membrane influence drug transport and nanoparticle-mediated drug delivery. Recent advances in membrane lipid research show the varied roles of lipids in regulating membrane P-glycoprotein function, membrane trafficking, apoptotic pathways, drug transport, and endocytic functions, particularly endocytosis, the primary mechanism of cellular uptake of nanoparticle-based drug delivery systems. Since acquired drug resistance alters lipid biosynthesis, understanding the role of lipids in cell membrane biophysics and its effect on drug transport is critical for developing effective therapeutic and drug delivery approaches to overcome drug resistance. Here we discuss novel strategies for (a) modulating the biophysical properties of membrane lipids of resistant cells to facilitate drug transport and regain endocytic function and (b) developing effective nanoparticles based on their biophysical interactions with membrane lipids to enhance drug delivery and overcome drug resistance.
© 2013.

Entities:  

Keywords:  ADR; AFM; Adriamycin-resistant; Apoptosis; Atomic force microscopic; CTAB; Cetyltrimethylammonium bromide; DMAB; Didodecyldimethylammonium bromide; ERC; ERCC1; Endocytic recycling compartment; Endocytosis; Excision repair cross-complementation group 1; GCS; Glucosylceramide synthase; HUVECs; Human umbilical vein endothelial cells; MDR; Membrane fluidity; Multidrug resistance; NP; Nanomedicine; Nanoparticle; P-glycoprotein efflux; P-gp; PC; PE; PS; Permeability glycoprotein; Phosphatidyl ethanolamine; Phosphatidyl serine; Phosphocholine; SM; SMase; Sphingomyelin; Sphingomyelinase; TAT; Trans-activating transcriptional

Mesh:

Substances:

Year:  2013        PMID: 24055719      PMCID: PMC3840112          DOI: 10.1016/j.addr.2013.09.004

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  131 in total

Review 1.  The Ceramide-centric universe of lipid-mediated cell regulation: stress encounters of the lipid kind.

Authors:  Yusuf A Hannun; Lina M Obeid
Journal:  J Biol Chem       Date:  2002-05-13       Impact factor: 5.157

Review 2.  The therapeutic potential of modulating the ceramide/sphingomyelin pathway.

Authors:  Richard Kolesnick
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

Review 3.  Multi-modal strategies for overcoming tumor drug resistance: hypoxia, the Warburg effect, stem cells, and multifunctional nanotechnology.

Authors:  Lara Milane; Shanthi Ganesh; Shruti Shah; Zhen-Feng Duan; Mansoor Amiji
Journal:  J Control Release       Date:  2011-04-08       Impact factor: 9.776

Review 4.  Lipid-mediated endocytosis.

Authors:  Helge Ewers; Ari Helenius
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-08-01       Impact factor: 10.005

Review 5.  Lipid polymorphisms and membrane shape.

Authors:  Vadim A Frolov; Anna V Shnyrova; Joshua Zimmerberg
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-11-01       Impact factor: 10.005

6.  Effect of pH on the interfacial tension of bilayer lipid membrane formed from phosphatidylcholine or phosphatidylserine.

Authors:  Aneta D Petelska; Zbigniew A Figaszewski
Journal:  Biochim Biophys Acta       Date:  2002-04-12

Review 7.  Multifactorial nature of tumor drug resistance.

Authors:  G I Solyanik
Journal:  Exp Oncol       Date:  2010-09

Review 8.  Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.

Authors:  Alina Shapira; Yoav D Livney; Henk J Broxterman; Yehuda G Assaraf
Journal:  Drug Resist Updat       Date:  2011-02-16       Impact factor: 18.500

9.  Pharmacokinetics and biodistribution of lonidamine/paclitaxel loaded, EGFR-targeted nanoparticles in an orthotopic animal model of multi-drug resistant breast cancer.

Authors:  Lara Milane; Zhen-feng Duan; Mansoor Amiji
Journal:  Nanomedicine       Date:  2011-01-08       Impact factor: 5.307

10.  Effect of molecular structure of cationic surfactants on biophysical interactions of surfactant-modified nanoparticles with a model membrane and cellular uptake.

Authors:  Chiranjeevi Peetla; Vinod Labhasetwar
Journal:  Langmuir       Date:  2009-02-17       Impact factor: 3.882

View more
  52 in total

1.  Sustained Epigenetic Drug Delivery Depletes Cholesterol-Sphingomyelin Rafts from Resistant Breast Cancer Cells, Influencing Biophysical Characteristics of Membrane Lipids.

Authors:  Vijay Raghavan; Sivakumar Vijayaraghavalu; Chiranjeevi Peetla; Masayoshi Yamada; Megan Morisada; Vinod Labhasetwar
Journal:  Langmuir       Date:  2015-10-15       Impact factor: 3.882

Review 2.  Cell membrane modulation as adjuvant in cancer therapy.

Authors:  Sara Zalba; Timo L M Ten Hagen
Journal:  Cancer Treat Rev       Date:  2016-11-09       Impact factor: 12.111

3.  Elucidation of underlying molecular mechanism of 5-Fluorouracil chemoresistance and its restoration using fish oil in experimental colon carcinoma.

Authors:  Isha Rani; Sandeep Kumar; Bhoomika Sharma; Rajendra Prasad; Satinder Kaur; Prerna Sharma; Navneet Agnihotri
Journal:  Mol Cell Biochem       Date:  2021-01-04       Impact factor: 3.396

4.  Codelivery of DNA and siRNA via arginine-rich PEI-based polyplexes.

Authors:  Shan Lu; Viola B Morris; Vinod Labhasetwar
Journal:  Mol Pharm       Date:  2015-01-15       Impact factor: 4.939

5.  Modulation of membrane properties of lung cancer cells by azurin enhances the sensitivity to EGFR-targeted therapy and decreased β1 integrin-mediated adhesion.

Authors:  Nuno Bernardes; Sofia Abreu; Filomena A Carvalho; Fábio Fernandes; Nuno C Santos; Arsénio M Fialho
Journal:  Cell Cycle       Date:  2016-04-20       Impact factor: 4.534

Review 6.  Hurdles in selection process of nanodelivery systems for multidrug-resistant cancer.

Authors:  P S Thakur; A M Khan; S Talegaonkar; F J Ahmad; Z Iqbal
Journal:  J Cancer Res Clin Oncol       Date:  2016-04-26       Impact factor: 4.553

Review 7.  Importance of integrating nanotechnology with pharmacology and physiology for innovative drug delivery and therapy - an illustration with firsthand examples.

Authors:  Rui Xue Zhang; Jason Li; Tian Zhang; Mohammad A Amini; Chunsheng He; Brian Lu; Taksim Ahmed; HoYin Lip; Andrew M Rauth; Xiao Yu Wu
Journal:  Acta Pharmacol Sin       Date:  2018-04-26       Impact factor: 6.150

Review 8.  Functional link between plasma membrane spatiotemporal dynamics, cancer biology, and dietary membrane-altering agents.

Authors:  Alfredo Erazo-Oliveras; Natividad R Fuentes; Rachel C Wright; Robert S Chapkin
Journal:  Cancer Metastasis Rev       Date:  2018-09       Impact factor: 9.264

9.  Azurin interaction with the lipid raft components ganglioside GM-1 and caveolin-1 increases membrane fluidity and sensitivity to anti-cancer drugs.

Authors:  Nuno Bernardes; Ana Rita Garizo; Sandra N Pinto; Bernardo Caniço; Catarina Perdigão; Fábio Fernandes; Arsenio M Fialho
Journal:  Cell Cycle       Date:  2018-08-04       Impact factor: 4.534

10.  Tuning the surface coating of IONs toward efficient sonochemical tethering and sustained liberation of topoisomerase II poisons.

Authors:  Hana Michalkova; Vladislav Strmiska; Jiri Kudr; Zuzana Skubalova; Barbora Tesarova; Pavel Svec; Lukas Richtera; Ondrej Zitka; Vojtech Adam; Zbynek Heger
Journal:  Int J Nanomedicine       Date:  2019-09-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.